Retrospective analysis of outcome in patients with nodal metastases from transitional cell carcinoma of lower urinary tract

Michael Koch, David M. Coussens

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Objective. To determine the outcome in patients with nodal metastases from transitional cell carcinoma (TCC) using currently available surgical and chemotherapeutic techniques. Methods. A retrospective analysis of all patients with TCC of the lower urinary tract who underwent radical cystectomy or lymph node dissection at our institution since 1980 was performed. Thirty-one patients were identified who had documented pelvic lymph node metastases prior to or at the time of radical cystectomy. These patients' records were reviewed in-depth with regard to treatment approach, presenting features, and outcome. Results. Outcome was poor despite the treatment approach taken, including whether or not chemotherapy was administered prior to or after cystectomy. Median survivals of patients receiving no chemotherapy, adjuvant chemotherapy, and neoadjuvant chemotherapy were 14.5, 9.5, and 15.0 months, respectively. Only 4 of 28 patients survived more than three years, and only one of these received chemotherapy. Conclusions. Survival of patients with lymph node metastases from transitional cell carcinoma remains poor despite aggressive surgical therapy and the use of adjuvant or neoadjuvant platinum-based chemotherapy.

Original languageEnglish (US)
Pages (from-to)317-323
Number of pages7
JournalUrology
Volume43
Issue number3
DOIs
StatePublished - 1994
Externally publishedYes

Fingerprint

Transitional Cell Carcinoma
Urinary Tract
Neoplasm Metastasis
Cystectomy
Drug Therapy
Lymph Nodes
Survival
Adjuvant Chemotherapy
Platinum
Lymph Node Excision
Therapeutics

ASJC Scopus subject areas

  • Urology

Cite this

Retrospective analysis of outcome in patients with nodal metastases from transitional cell carcinoma of lower urinary tract. / Koch, Michael; Coussens, David M.

In: Urology, Vol. 43, No. 3, 1994, p. 317-323.

Research output: Contribution to journalArticle

@article{0394b94cc94f403c96bd058b02c69378,
title = "Retrospective analysis of outcome in patients with nodal metastases from transitional cell carcinoma of lower urinary tract",
abstract = "Objective. To determine the outcome in patients with nodal metastases from transitional cell carcinoma (TCC) using currently available surgical and chemotherapeutic techniques. Methods. A retrospective analysis of all patients with TCC of the lower urinary tract who underwent radical cystectomy or lymph node dissection at our institution since 1980 was performed. Thirty-one patients were identified who had documented pelvic lymph node metastases prior to or at the time of radical cystectomy. These patients' records were reviewed in-depth with regard to treatment approach, presenting features, and outcome. Results. Outcome was poor despite the treatment approach taken, including whether or not chemotherapy was administered prior to or after cystectomy. Median survivals of patients receiving no chemotherapy, adjuvant chemotherapy, and neoadjuvant chemotherapy were 14.5, 9.5, and 15.0 months, respectively. Only 4 of 28 patients survived more than three years, and only one of these received chemotherapy. Conclusions. Survival of patients with lymph node metastases from transitional cell carcinoma remains poor despite aggressive surgical therapy and the use of adjuvant or neoadjuvant platinum-based chemotherapy.",
author = "Michael Koch and Coussens, {David M.}",
year = "1994",
doi = "10.1016/0090-4295(94)90072-8",
language = "English (US)",
volume = "43",
pages = "317--323",
journal = "Urology",
issn = "0090-4295",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Retrospective analysis of outcome in patients with nodal metastases from transitional cell carcinoma of lower urinary tract

AU - Koch, Michael

AU - Coussens, David M.

PY - 1994

Y1 - 1994

N2 - Objective. To determine the outcome in patients with nodal metastases from transitional cell carcinoma (TCC) using currently available surgical and chemotherapeutic techniques. Methods. A retrospective analysis of all patients with TCC of the lower urinary tract who underwent radical cystectomy or lymph node dissection at our institution since 1980 was performed. Thirty-one patients were identified who had documented pelvic lymph node metastases prior to or at the time of radical cystectomy. These patients' records were reviewed in-depth with regard to treatment approach, presenting features, and outcome. Results. Outcome was poor despite the treatment approach taken, including whether or not chemotherapy was administered prior to or after cystectomy. Median survivals of patients receiving no chemotherapy, adjuvant chemotherapy, and neoadjuvant chemotherapy were 14.5, 9.5, and 15.0 months, respectively. Only 4 of 28 patients survived more than three years, and only one of these received chemotherapy. Conclusions. Survival of patients with lymph node metastases from transitional cell carcinoma remains poor despite aggressive surgical therapy and the use of adjuvant or neoadjuvant platinum-based chemotherapy.

AB - Objective. To determine the outcome in patients with nodal metastases from transitional cell carcinoma (TCC) using currently available surgical and chemotherapeutic techniques. Methods. A retrospective analysis of all patients with TCC of the lower urinary tract who underwent radical cystectomy or lymph node dissection at our institution since 1980 was performed. Thirty-one patients were identified who had documented pelvic lymph node metastases prior to or at the time of radical cystectomy. These patients' records were reviewed in-depth with regard to treatment approach, presenting features, and outcome. Results. Outcome was poor despite the treatment approach taken, including whether or not chemotherapy was administered prior to or after cystectomy. Median survivals of patients receiving no chemotherapy, adjuvant chemotherapy, and neoadjuvant chemotherapy were 14.5, 9.5, and 15.0 months, respectively. Only 4 of 28 patients survived more than three years, and only one of these received chemotherapy. Conclusions. Survival of patients with lymph node metastases from transitional cell carcinoma remains poor despite aggressive surgical therapy and the use of adjuvant or neoadjuvant platinum-based chemotherapy.

UR - http://www.scopus.com/inward/record.url?scp=0028208654&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028208654&partnerID=8YFLogxK

U2 - 10.1016/0090-4295(94)90072-8

DO - 10.1016/0090-4295(94)90072-8

M3 - Article

C2 - 8134985

AN - SCOPUS:0028208654

VL - 43

SP - 317

EP - 323

JO - Urology

JF - Urology

SN - 0090-4295

IS - 3

ER -